Fundação Getulio Vargas is one of the highlights of the article The growing importance of courses for investors, published in Valor Online today. According to the media vehicle, FGV is one of the pioneers in teaching and the dissemination of knowledge for the education of entrepreneurs and investors in Brazil.  The report mentions the Center for the Study of Private Equity and Venture Capital (GVcepe) of São Paulo School of Business Administration (FGV/EAESP) and it operates on two fronts: generation of information and education.On one hand, it conducts in-depth studies on the Brazilian ecosystem of venture capital, whose second edition is about to be released including 120 private equity management organizations and 285 investment vehicles, with 723 mapped companies which receive investment, he explained, and then he recalled the initiatives to promote entrepreneurship. On another front, it created the program Desafio Brasil, which has partners such as Intel, Vivo and Ministry of Industry, Trade and Development and has just completed its eighth edition with an awards event and the selection of 30 finalists among 1044 registrations, of which 140 passed the mentoring and selection phases.According to the executive director of GVcepe, Cláudio Furtado, the country still crawls in the startups sector. In advanced economies, the private equity industry accounts for 1% of the GDP. In Brazil, it is still at 0.34%, he said. However, the numbers are promising. With an average of US$ 7.6 billion per year from 2010 to 2012 and 56% growth in the number of venture capital management organizations, the sector has directed US$ 300 million in high growth technology-based venture capital, says the article.Desafio Brasil (Challenge Brazil)The goal is to train startup entrepreneurs who qualify to receive venture capital investments, says Furtado. This year, the 8th edition of Desafio Brasil received more than 1,800 proposals, which were evaluated and advised by 611 volunteering experts.The winning start-up was PluriCell Biotechnologies - which works with technology to generate multiple human cell types from stem cells, enabling the reduction of animal testing.Registration for Desafio Brasil will be open again in February 2014.